Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 1, Pages 307
Publisher
MDPI AG
Online
2018-01-22
DOI
10.3390/ijms19010307
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy
- (2017) Paola Ulivi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Deregulation of hsa-miR-20b expression in TNF-α-induced premature senescence of human pulmonary microvascular endothelial cells
- (2017) Pooi-Fong Wong et al. MICROVASCULAR RESEARCH
- Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer
- (2017) Sabine Tejpar et al. JAMA Oncology
- Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer
- (2017) Kentaro Inamura Cancers
- Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab
- (2017) Giorgia Marisi et al. Scientific Reports
- Expression and Function of miR-155 in Diseases of the Gastrointestinal Tract
- (2016) Jianhua Wan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-199a-5p inhibits tumor proliferation in melanoma by mediating HIF-1α
- (2016) XINGHUA YANG et al. Molecular Medicine Reports
- A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumab
- (2016) Josie Hayes et al. Molecular Oncology
- Role of Mir-155 in Controlling HIF-1α Level and Promoting Endothelial Cell Maturation
- (2016) Deguang Yang et al. Scientific Reports
- Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular Thyroid Carcinoma
- (2016) Dawei Sun et al. MEDICAL SCIENCE MONITOR
- MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment
- (2016) Kentaro Inamura et al. Journal of Clinical Medicine
- Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial
- (2015) A. Passardi et al. ANNALS OF ONCOLOGY
- Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
- (2015) T F Hansen et al. BRITISH JOURNAL OF CANCER
- MicroRNA-155 Exerts Cell-Specific Antiangiogenic but Proarteriogenic Effects During Adaptive NeovascularizationCLINICAL PERSPECTIVE
- (2015) Franziska Pankratz et al. CIRCULATION
- Predictive tissue biomarkers for bevacizumab-containing therapy in metastatic colorectal cancer: an update
- (2015) Koen M Marien et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN
- (2015) Hongyan Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05)
- (2014) M. Joerger et al. LUNG CANCER
- MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2
- (2014) ZhiFeng Sun et al. MEDICAL ONCOLOGY
- The Oncogenic MicroRNA Hsa-miR-155-5p Targets the Transcription Factor ELK3 and Links It to the Hypoxia Response
- (2014) E. Douglas Robertson et al. PLoS One
- Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab
- (2014) Mogens K. Boisen et al. PLoS One
- MicroRNAs in colorectal cancer: Role in metastasis and clinical perspectives
- (2014) Shan Muhammad WORLD JOURNAL OF GASTROENTEROLOGY
- Hsa-miR-520d induces hepatoma cells to form normal liver tissues via a stemness-mediated process
- (2014) Satoshi Tsuno et al. Scientific Reports
- MicroRNAs: Promising New Antiangiogenic Targets in Cancer
- (2014) Sandra Gallach et al. Biomed Research International
- Local Inhibition of MicroRNA-24 Improves Reparative Angiogenesis and Left Ventricle Remodeling and Function in Mice With Myocardial Infarction
- (2013) Marco Meloni et al. MOLECULAR THERAPY
- Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
- (2013) W Kong et al. ONCOGENE
- MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17
- (2012) Ke Xu et al. EXPERIMENTAL CELL RESEARCH
- Angiogenesis-related microRNAs in colon cancer
- (2012) Liu Hong et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis
- (2012) Keun Hur et al. GUT
- Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer
- (2012) Ziad Kanaan et al. HUMAN MUTATION
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
- (2012) Douglas G. Altman et al. PLOS MEDICINE
- MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression
- (2011) Jian-Hong Fang et al. HEPATOLOGY
- Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer
- (2011) Xueqing Wang et al. MEDICAL ONCOLOGY
- Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells
- (2010) Chao-Jie Wang et al. BMC CANCER
- miR-126 Regulates Angiogenic Signaling and Vascular Integrity
- (2008) Jason E. Fish et al. DEVELOPMENTAL CELL
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study
- (2008) Howard S. Hochster et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search